Sigal

Tessera Therapeutics Appoints Industry Leaders Elliott Sigal & Mary Rozenman to Board of Directors

Retrieved on: 
Tuesday, June 15, 2021

Tessera Therapeutics, a biotech company pioneering Gene Writing, announced today the appointment of Elliott Sigal, M.D., Ph.D. and Mary Rozenman, Ph.D. to the companys Board of Directors.

Key Points: 
  • Tessera Therapeutics, a biotech company pioneering Gene Writing, announced today the appointment of Elliott Sigal, M.D., Ph.D. and Mary Rozenman, Ph.D. to the companys Board of Directors.
  • Elliott and Mary bring phenomenal leadership, experience, and creativity to Tesseras Board of Directors, said Geoffrey von Maltzahn, Ph.D., CEO and Co-Founder of Tessera.
  • Dr. Sigal brings decades of clinical experience in drug discovery, drug development, and corporate strategy to Tesseras Board of Directors.
  • Dr. Rozenman brings more than 15 years of scientific expertise, company building, and transactions leadership in the biotech industry to Tesseras Board of Directors.

ADT Appoints Sigal Zarmi To the Company’s Board of Directors

Retrieved on: 
Monday, April 5, 2021

BOCA RATON, Fla., April 05, 2021 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) a leading provider of security, automation, and smart home solutions serving consumer and business customers in the United States, today announced the appointment of Sigal Zarmi to the companys board of directors as an additional independent director.

Key Points: 
  • BOCA RATON, Fla., April 05, 2021 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) a leading provider of security, automation, and smart home solutions serving consumer and business customers in the United States, today announced the appointment of Sigal Zarmi to the companys board of directors as an additional independent director.
  • We are pleased to welcome Sigal to our board of directors, said Marc Becker, ADT chairman of the board.
  • I am thrilled to be joining the board of ADT, Zarmi said.
  • It is an exciting time for ADT as it introduces truly innovative cloud, AI and ML solutions to the smart home security industry.

Cellcom Israel Ltd. Announces Appointment Of VP Business Development And CEO Of Golan Telecom

Retrieved on: 
Monday, October 12, 2020

NETANYA, Israel, Oct. 12, 2020 /PRNewswire/ --Cellcom Israel Ltd. (NYSE: CEL) (the "Company") announced today the appointment ofMr.

Key Points: 
  • NETANYA, Israel, Oct. 12, 2020 /PRNewswire/ --Cellcom Israel Ltd. (NYSE: CEL) (the "Company") announced today the appointment ofMr.
  • Ilan Sigal as the Company's VP business development and as CEO of Golan Telecom (a wholly owned subsidiary of the Company) effective February 1, 2021.
  • Cellcom Israel Ltd., established in 1994, is a leading Israeli communications group, providing a wide range of communications services.
  • Cellcom Israel further provides OTT TV services, internet infrastructure and connectivity services and international calling services, as well as landline telephone services in Israel.

Filterlex Medical Raised $3M in Series A Financing

Retrieved on: 
Monday, July 15, 2019

YOKNEAM, Israel, July 15, 2019 /PRNewswire/ -- Filterlex Medical is a medical device start-up company, developing an innovative embolic protection device (CAPTIS) for reducing the risk of stroke and other complications during catheter-based structural heart procedures.

Key Points: 
  • YOKNEAM, Israel, July 15, 2019 /PRNewswire/ -- Filterlex Medical is a medical device start-up company, developing an innovative embolic protection device (CAPTIS) for reducing the risk of stroke and other complications during catheter-based structural heart procedures.
  • The company recently completed a series A round of financing, raising a total of $3M.
  • Filterlex Medical, located inYokneam, Israel, began operating in June 2016 at the Alon MedTech Ventures incubator owned by Dr. Shimon Eckhouse, a pioneer technological entrepreneur and a leading investor in the field of medical devices.
  • Leading interventional cardiologists and top industry executives selected CAPTIS for the Best Innovation Award," said Sigal Eli, founder, inventor and CEO of Filterlex Medical.

Filterlex Medical Raised $3M in Series A Financing

Retrieved on: 
Monday, July 15, 2019

YOKNEAM, Israel, July 15, 2019 /PRNewswire/ -- Filterlex Medical is a medical device start-up company, developing an innovative embolic protection device (CAPTIS) for reducing the risk of stroke and other complications during catheter-based structural heart procedures.

Key Points: 
  • YOKNEAM, Israel, July 15, 2019 /PRNewswire/ -- Filterlex Medical is a medical device start-up company, developing an innovative embolic protection device (CAPTIS) for reducing the risk of stroke and other complications during catheter-based structural heart procedures.
  • The company recently completed a series A round of financing, raising a total of $3M.
  • Filterlex Medical, located inYokneam, Israel, began operating in June 2016 at the Alon MedTech Ventures incubator owned by Dr. Shimon Eckhouse, a pioneer technological entrepreneur and a leading investor in the field of medical devices.
  • Leading interventional cardiologists and top industry executives selected CAPTIS for the Best Innovation Award," said Sigal Eli, founder, inventor and CEO of Filterlex Medical.

Borealis AI expands lab network into Vancouver

Retrieved on: 
Monday, April 23, 2018

TORONTO, April 23, 2018 /CNW/ -Building off its recent investments in the Canadian artificial intelligence (AI) ecosystem, Borealis AI today announced it is expanding its network of labs across Canada into Vancouver.

Key Points: 
  • TORONTO, April 23, 2018 /CNW/ -Building off its recent investments in the Canadian artificial intelligence (AI) ecosystem, Borealis AI today announced it is expanding its network of labs across Canada into Vancouver.
  • Both professors will continue to teach at their respective universities while working with Borealis AI.
  • "Borealis AI is a young, vibrant research organization with exceptional technical talent and a unique mandate for balanced curiosity-driven and applied AI research; it's at the forefront of the Canadian AI ecosystem," says Prof. Sigal.
  • Vancouver is an emerging city in AI research thanks to an already established talent pool in visual computing and graphics.